BRCA1 and ovarian carcinoma: Additionally, an ovarian cancer patient who was negative for the highly -penetrant BRCA1 variant was found to carry a heterozygous form of the 2q34 deletion, suggesting that the deletion may also contribute to ovarian cancer risk to some extent (Figure 1).